Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The conversion of excitatory sensory neuron phenotypes into inhibitory ones refers primarily to a plasticity mechanism where certain spinal interneurons change their core neurotransmitter output following specific insults like spinal cord trauma. This shift alters neural circuit dynamics with significant implications for both disease progression and therapeutic intervention strategies. This involves a switch in neurotransmitter identity—whereby neurons that typically release excitatory neurotransmitters (like glutamate) begin expressing and releasing inhibitory neurotransmitters (such as GABA or glycine).
Modulation of neurotransmitter phenotype switching; e.g., preventing the excitatory to inhibitory conversion or promoting the reverse
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Sensory neuron (conversion of excitatory to inhibitory phenotype).